Skip to main content
Home
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
6 search results for:

ATTD 2022 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 29-04-2022 | ATTD 2022 | News | Article

    Poor glucose control risks SARS-CoV-2 infection despite immunization in type 2 diabetes

    Nat Commun 2022; 13 : 2318 ATTD 2022; Barcelona, Spain: 27–30 April

    Author:
    Eleanor McDermid
    Published in:
    Nat Commun 2022; 13 : 2318 ATTD 2022; Barcelona, Spain: 27–30 April
  2. 29-04-2022 | ATTD 2022 | News | Article
    News in brief

    Concentrated rapid-acting insulin shows early promise

    Svehlikova noted that, besides providing a smaller injection volume so that people with high insulin needs do not need to split their injections, concentrated insulins also facilitate the development of smaller injection devices. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ATTD 2022; Barcelona, Spain: 27–30 April

    Author:
    Eleanor McDermid
    Published in:
    ATTD 2022; Barcelona, Spain: 27–30 April
  3. 29-04-2022 | ATTD 2022 | News | Article

    Most sensor-detected hypoglycemia goes unnoticed by people with diabetes

    He noted that the Hypo-METRICS study will also investigate whether asymptomatic hypoglycemic events are detrimental for people with diabetes. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ATTD 2022; Barcelona, Spain: 27–30 April

    Author:
    Eleanor McDermid
    Published in:
    ATTD 2022; Barcelona, Spain: 27–30 April
  4. 06-05-2022 | Type 1 diabetes | News | Article

    Transdermal capillary blood sampling could simplify C-peptide measurement

    Besser said: “I think what this reflects is that in our pediatric practice we tend to use numbing cream or cold spray […] and we aim not to cause pain with venous sampling.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ATTD 2022; Barcelona, Spain: 27–30 April

    Author:
    Eleanor McDermid
    Published in:
    ATTD 2022; Barcelona, Spain: 27–30 April
  5. 04-05-2022 | Artificial pancreas systems | News | Article

    Real-world study probes artificial pancreas system differences

    “We believe that understanding the strengths and the limitations of [advanced hybrid closed-loop] devices will help us tailor pump therapy and then choose the right device depending on the patient that we have before us,” Strati concluded. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ATTD 2022; Barcelona, Spain: 27–30 April

    Author:
    Eleanor McDermid
    Published in:
    ATTD 2022; Barcelona, Spain: 27–30 April
  6. 15-03-2022 | Artificial pancreas systems | News | Article

    High use, improved glucose control in older adults with Cambridge closed-loop system

    Nonetheless, they conclude that “this study is an important step toward building the evidence base for optimal management of the growing population of older adults with type 1 diabetes.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group Lancet Healthy Longev 2022; 3 : e135–142 Lancet Healthy Longev 2022; 3 : e120–121

    Author:
    Eleanor McDermid
    Published in:
    Lancet Healthy Longev 2022; 3 : e135–142 Lancet Healthy Longev 2022; 3 : e120–121
  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.